Clinical Trials Browser

Phase 2 × Gemcitabine × Gynecologic × Clear all

NCT02101775 2026-04-13

Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Active not recruiting

124 enrolled 17 charts

Brenner Tumor, Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT02595892 2026-04-13

Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Active not recruiting

70 enrolled 23 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07504588 2026-04-13

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Phase 2 Not yet recruiting

Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma

NCT05548296 2026-03-24

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Phase 2 Recruiting

Endometrial Neoplasms

NCT00421096 2026-03-13

GEMCOL

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT05481645 2026-01-09

Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.

Phase 2 Terminated

GynecologicSarcoma

Advanced Endometrial Cancer

NCT06630325 2026-01-07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Active not recruiting

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT02364713 2025-12-11

MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer

Phase 2 Terminated

17 enrolled 14 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06710288 2025-10-20

A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

Phase 2 Recruiting

Platinum-resistant Ovarian Cancer

NCT05007106 2025-08-14

KEYVIBE-005

Phase 2 Completed

BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT04680988 2025-08-05

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Phase 2 Completed

Uterine Cervical Neoplasms, Recurrence

NCT06023862 2025-06-15

DOVE

Phase 2 Recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT03783949 2025-06-11

EUDARIO

Phase 2 Completed

122 enrolled 23 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Phase 2 Recruiting

Uterine Cervical Neoplasms, Renal Insufficiency

NCT04274426 2025-04-06

MIROVA

Phase 2 Active not recruiting

Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma

NCT02489903 2025-03-17

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Phase 2 Completed

139 enrolled 14 charts

EndocrineGynecologicNETThoracic

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

NCT02312245 2024-12-05

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

13 enrolled 14 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01696032 2024-08-27

SGI-110

Phase 2 Completed

120 enrolled 22 charts

Ovarian Neoplasms

NCT02272790 2023-10-03

Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

95 enrolled 61 charts

Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation

NCT05979298 2023-08-07

Efficacy of Plasmid Elenagen in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer

Phase 2 Unknown

Ovarian Neoplasms

NCT00003518 2023-06-22

Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors

Phase 2 Completed

GenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Testicular Neoplasms

NCT05733000 2023-03-10

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Phase 2 Recruiting

GastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma of Lung, Carcinoma, Transitional Cell, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03386721 2023-02-21

Basket Study to Evaluate the Therapeutic Activity of Simlukafusp Alfa as a Combination Therapy in Participants With Advanced and/or Metastatic Solid Tumors

Phase 2 Terminated

256 enrolled 26 charts

Uterine Cervical Neoplasms

NCT02608684 2022-03-23

PemCiGem

Phase 2 Completed

21 enrolled 16 charts

Ovarian Neoplasms

NCT01595061 2021-12-29

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

Phase 2 Unknown

57 enrolled 11 charts

Vulvar Neoplasms

NCT03657966 2021-04-21

DCVAC/OvCa After Standard-of-care Chemotherapy in Women With Relapse of Platinum-sensitive Epithelial Ovarian Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01610206 2021-02-25

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

Phase 2 Completed

148 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT02822157 2021-01-29

CLIO

Phase 2 Unknown

Carcinoma, Ovarian Epithelial

NCT00227721 2020-12-02

Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer

Phase 2 Completed

30 enrolled 7 charts

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00114218 2019-01-08

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

28 enrolled 7 charts

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT02107950 2018-08-15

Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian Carcinoma

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT03539328 2018-05-29

MITO27

Phase 2 Unknown

Ovarian Neoplasms

NCT01936974 2018-02-20

PGA

Phase 2 Terminated

7 enrolled 1 chart

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00820898 2017-12-29

Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

24 enrolled 7 charts

Endometrial Adenocarcinoma

NCT00610740 2017-12-28

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

Phase 2 Completed

18 enrolled 8 charts

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT00061308 2017-06-09

Second-line Intravenous Treatment For Recurrent Platinum-Sensitive Ovarian, Fallopian, Or Peritoneal Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00031629 2016-12-08

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Phase 2 Completed

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT00031954 2015-12-23

Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02309658 2015-10-16

Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer Patients

Phase 2 Completed

Uterine Cervical Neoplasms

NCT01121406 2015-08-13

BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer

Phase 2 Completed

110 enrolled 32 charts

Ovarian Neoplasms

NCT00096993 2015-06-10

A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

131 enrolled 11 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00267696 2015-04-30

Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase 2 Completed

45 enrolled 14 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01196559 2015-02-18

Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00312650 2015-01-12

Doxil and Gemcitabine in Recurrent Ovarian Cancer

Phase 2 Terminated

Ovarian Neoplasms, Recurrence

NCT02004093 2014-12-04

A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer

Phase 2 Completed

149 enrolled 20 charts

Ovarian Neoplasms

NCT00282087 2014-12-01

Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma

Phase 2 Completed

47 enrolled 16 charts

GynecologicSarcoma

Leiomyosarcoma, Uterine Neoplasms

NCT00388154 2014-11-13

Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer

Phase 2 Completed

21 enrolled 14 charts

Endometrial Neoplasms

NCT00928642 2014-10-21

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

Phase 2 Completed

8 enrolled 8 charts

Neoplasms, Ovarian Neoplasms

NCT00418093 2014-06-19

Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma

Phase 2 Terminated

19 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00003449 2014-05-22

Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms